Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewis, G. F.
Right arrow Articles by Giacca, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewis, G. F.
Right arrow Articles by Giacca, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 48, Issue 3 570-576, Copyright © 1999 by American Diabetes Association


ARTICLES

Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes

GF Lewis, A Carpentier, M Vranic and A Giacca
Department of Medicine, University of Toronto, Ontario, Canada. glewis@torhosp.toronto.on.ca

We and others have shown that insulin acutely suppresses glucose production in fasting nondiabetic humans and dogs, by both a direct hepatic effect and an indirect (extrahepatic) effect, and in diabetic dogs by an indirect effect alone. In type 2 diabetes, there is resistance to insulin's ability to suppress hepatic glucose production, but it has not previously been determined whether the resistance is primarily at the level of the hepatocyte or the peripheral tissues. To determine whether the diabetic state reduces the direct effect of insulin in humans, we studied nine patients with untreated type 2 diabetes who underwent three studies each, 4-6 weeks apart. 1) Portal study (POR): intravenous tolbutamide was infused for 3 h with calculation of pancreatic insulin secretion from peripheral plasma C-peptide. 2) Peripheral study (PER): equidose insulin was infused by peripheral vein. 3) Half-dose peripheral insulin study (1/2 PER): matched peripheral insulin levels with study 1. In all studies, glucose was clamped at euglycemia, glucose turnover was measured with the constant specific activity method, and 3-[3H]glucose was purified by high-performance liquid chromatography. Peripheral insulin was lower in POR versus PER but slightly higher in POR versus 1/2 PER, although most of the difference could be accounted for by higher proinsulin levels in POR (stimulated by tolbutamide). Calculated portal insulin was approximately 1.3-fold higher in POR versus PER and approximately 2.2-fold higher in POR versus 1/2 PER. In the final 30 min of the clamp, glucose production reached a lower steady-state level in PER than in POR (4.0 +/- 0.4 vs. 5.3 +/- 0.5 pmol(-1) x kg(-1) x min(-1), P < 0.05), despite the higher hepatic insulin level in POR. In contrast with our studies in nondiabetic individuals, glucose production was not more suppressed at steady state in POR versus 1/2 PER (5.3 +/- 0.4 micromol x kg(-1) x min(-1)), despite much higher hepatic insulin levels in POR. In conclusion, this is the first study in patients with type 2 diabetes to characterize insulin resistance to the acute direct suppressive effect of insulin on hepatic glucose production.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J EndocrinolHome page
N. Gupta, E. Park, H. Sandhu, T. Goh, V. Tchipashvili, and A. Giacca
Direct and indirect effects of insulin on hepatic glucose production in diabetic depancreatized dogs during euglycemia.
J. Endocrinol., September 1, 2006; 190(3): 695 - 702.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
K. G. Tolman, V. Fonseca, M. H. Tan, and A. Dalpiaz
Narrative Review: Hepatobiliary Disease in Type 2 Diabetes Mellitus
Ann Intern Med, December 21, 2004; 141(12): 946 - 956.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. C. Camacho, R. R. Pencek, D. B. Lacy, F. D. James, and D. H. Wasserman
Suppression of Endogenous Glucose Production by Mild Hyperinsulinemia During Exercise Is Determined Predominantly by Portal Venous Insulin
Diabetes, February 1, 2004; 53(2): 285 - 293.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Gupta, H. Sandhu, T. Goh, K. Shah, S. R. Wiesenthal, H. Yoshii, V. Chong, T. K. T. Lam, C. A. Haber, W. Williams, et al.
Insulin inhibits glucose production by a direct effect in diabetic depancreatized dogs during euglycemia
Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1002 - E1007.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Staehr, O. Hother-Nielsen, K. Levin, J. J. Holst, and H. Beck-Nielsen
Assessment of Hepatic Insulin Action in Obese Type 2 Diabetic Patients
Diabetes, June 1, 2001; 50(6): 1363 - 1370.
[Abstract] [Full Text]


Home page
DiabetesHome page
P. N. Båvenholm, J. Pigon, C.-G. Östenson, and S. Efendic
Insulin Sensitivity of Suppression of Endogenous Glucose Production Is the Single Most Important Determinant of Glucose Tolerance
Diabetes, June 1, 2001; 50(6): 1449 - 1454.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
P. H Bisschop, J. de Metz, M. T Ackermans, E. Endert, H. Pijl, F. Kuipers, A. J Meijer, H. P Sauerwein, and J. A Romijn
Dietary fat content alters insulin-mediated glucose metabolism in healthy men
Am. J. Clinical Nutrition, March 1, 2001; 73(3): 554 - 559.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1999 by the American Diabetes Association.